Chemical activators of Olr556 utilize various molecular pathways to modulate the protein's activity. Forskolin, by directly activating adenylyl cyclase, raises intracellular cyclic AMP levels, which in turn activate protein kinase A (PKA). PKA is known to phosphorylate a myriad of proteins, and in the case of Olr556, this phosphorylation results in its activation. Similarly, Phorbol 12-myristate 13-acetate (PMA) engages protein kinase C (PKC), another kinase that phosphorylates proteins. The activation of PKC by PMA may lead to the phosphorylation of Olr556, modifying its activity. Ionomycin functions as a calcium ionophore, which increases intracellular calcium concentrations and activates calcium-dependent kinases, potentially leading to the phosphorylation of Olr556. BAY K8644 operates as an L-type calcium channel agonist, also boosting calcium levels within the cell, which can lead to Olr556 activation through calcium-stimulated phosphorylation.
Furthermore, Thapsigargin elevates cytosolic calcium by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which could activate calcium-dependent kinases that phosphorylate Olr556. Ouabain, by inhibiting Na+/K+ ATPase, alters intracellular ion gradients and may activate specific kinases that lead to the phosphorylation of Olr556. Zinc Pyrithione elevates intracellular zinc levels, which can activate zinc-sensitive kinases that then phosphorylate Olr556. Okadaic Acid, a protein phosphatase inhibitor, prevents the dephosphorylation of proteins, potentially leading to sustained activation of Olr556 if it is normally regulated by such phosphatases. Anisomycin activates stress-activated protein kinases (SAPKs), which may phosphorylate Olr556 if it is among their substrates. Veratridine, acting as a sodium channel agonist, could initiate the activation of sodium-sensitive kinases, possibly leading to Olr556 phosphorylation. H-89 Dihydrochloride, as a PKA inhibitor, may induce the activation of alternative kinases that phosphorylate Olr556. Lastly, Calyculin A prevents the dephosphorylation of proteins by inhibiting protein phosphatases like PP1 and PP2A, which may result in the maintenance of Olr556 in a phosphorylated, active state.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate Olr556. Activation of PKC results in altered phosphorylation states of many proteins, and if Olr556 is a substrate for PKC, this would result in its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels. Increased calcium can activate calcium-dependent protein kinases, which may phosphorylate and activate Olr556. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
BAY K8644 is an L-type calcium channel agonist that increases intracellular calcium concentrations. The increased calcium can activate protein kinases that phosphorylate and activate Olr556. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels. This activates calcium-dependent kinases that could phosphorylate and activate Olr556. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Ouabain inhibits Na+/K+ ATPase, altering intracellular ion gradients. The resulting changes in cellular signaling can activate kinases that may phosphorylate and activate Olr556. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Zinc Pyrithione increases intracellular zinc levels, which can influence various signaling pathways. Zinc-sensitive kinases might phosphorylate and activate Olr556 in response to elevated zinc levels. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, preventing dephosphorylation of proteins. This may result in the sustained phosphorylation and activation of Olr556 if it is normally regulated by these phosphatases. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases (SAPKs). If Olr556 is a SAPK substrate, anisomycin-induced SAPK activation could lead to the phosphorylation and functional activation of Olr556. | ||||||
Veratridine | 71-62-5 | sc-201075B sc-201075 sc-201075C sc-201075A | 5 mg 10 mg 25 mg 50 mg | $80.00 $102.00 $197.00 $372.00 | 3 | |
Veratridine acts as a sodium channel agonist, leading to sodium influx and potential activation of sodium-sensitive kinases, which could phosphorylate and activate Olr556. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $92.00 $182.00 | 71 | |
H-89 inhibits PKA, which could lead to compensatory activation of other kinases that phosphorylate and activate Olr556. | ||||||